{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:11:26Z","timestamp":1768914686942,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.tcm.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T11:46:52Z","timestamp":1638359212000},"page":"90-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Editorial commentary: Highlighting the ray of hope in Danon disease research after 40 years"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-4687","authenticated-orcid":false,"given":"Kazuma","family":"Sugie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2021.11.007_bib0001","article-title":"Clinical features of Danon disease and insights gained from LAMP-2 deficiency models","author":"Zhai","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.tcm.2021.11.007_bib0002","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnen\/64.6.513","article-title":"Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies","volume":"64","author":"Sugie","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.tcm.2021.11.007_bib0003","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"issue":"6798","key":"10.1016\/j.tcm.2021.11.007_bib0004","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.tcm.2021.11.007_bib0005","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.58.12.1773","article-title":"Clinicopathological features of genetically confirmed Danon disease","volume":"58","author":"Sugie","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tcm.2021.11.007_bib0006","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/nan.12587","article-title":"Review: Danon disease: review of natural history and recent advances","volume":"46","author":"Cenacchi","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"11","key":"10.1016\/j.tcm.2021.11.007_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113507","article-title":"A nationwide survey on danon disease in Japan","volume":"19","author":"Sugie","year":"2018","journal-title":"Int J Mol Sci."},{"issue":"6798","key":"10.1016\/j.tcm.2021.11.007_bib0008","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/35022595","article-title":"Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice","volume":"406","author":"Tanaka","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tcm.2021.11.007_bib0009","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12016-017-8598-3","article-title":"A critical evaluation of liver pathology in humans with danon disease and experimental correlates in a rat model of LAMP-2 deficiency","volume":"53","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.tcm.2021.11.007_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2019.06.013","article-title":"Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy","volume":"133","author":"Dvornikov","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.tcm.2021.11.007_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102158","article-title":"A heterozygous MYH7 (c. 2156G >A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy","volume":"51","author":"Li","year":"2021","journal-title":"Stem Cell Res"},{"issue":"1","key":"10.1016\/j.tcm.2021.11.007_bib0012","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1038\/s41598-018-21602-8","article-title":"Small-Vessel Vasculopathy Due to Aberrant Autophagy in LAMP-2 Deficiency","volume":"8","author":"Nguyen","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.tcm.2021.11.007_bib0013","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1073\/pnas.1808618116","article-title":"LAMP-2B regulates human cardiomyocyte function by mediating autophagosome-lysosome fusion","volume":"116","author":"Chi","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"535","key":"10.1016\/j.tcm.2021.11.007_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax1744","article-title":"Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease","volume":"12","author":"Manso","year":"2020","journal-title":"Sci Transl Med"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173821001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173821001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:03:31Z","timestamp":1760936611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173821001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1050173821001419"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2021.11.007","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial commentary: Highlighting the ray of hope in Danon disease research after 40 years","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2021.10.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}